4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-031086
Chief Executive Officer gave up 132,000 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2017-05-05 | Shares withheld for taxes | −132,000 | $7.12 | $939,840 | 1,077,291 | D |
Loading xslF345X03/doc4.xml…